1/6

Used Medical Equipment

 

We work directly with facilities that have retired medical equipment to sell. All equipment we buy is paid for prior to removing it from your facility with no additional charge for removal. This provides healthcare facilities with a timely revenue source and alleviates costly handling and storage.

 

Refurbished

 

Refurbished equipment is available for sites with a need for "like new" equipment at 40-60% the price of new. We provide completely refurbished medical equipment that will endure the life and integrity of a new product. Each unit is rebuilt with reconditioned base parts; rebuilt hydraulics and pumps, sand and re-paint all metal surfaces, re-coat all plastic and rubber components (bumps, grips, handrails or handles), and new padding and/or vinyl surfaces. All equipment is brought up to OEM specifications and condition, to include both biomedical certification and warranty. Our equipment truly looks and performs like new!

January 06, 2017

A radiation machine goes on the fritz during a patient’s treatment. A da Vinci surgical robot glitches out in the middle of a procedure. The defibrillator goes quiet during resuscitation.

These events can’t happen. And outside of rare scenarios, doctors and nurses aren’t trained to service these machines.

Servicing machines in the medical field is more mission-critical than almost any other industry: Without working equipment, people’s lives are on the line. And there are huge financial implications at stake when talking about investments in multi-million dollar machines whose usage dictates revenue for the organization. A down machine equals lost billings.

Enter medical field service technicians, the people keeping dialysis and radiation therapy machines and even hospital beds functioning up to the standards that patients and their physicians expect.

Technology and cloud-enabled service keeps equipment streaming data and “talking” at all times, helping manufacturers identify patterns of outages and anticipate when they might occur next.

Why manufacturers need to stay at the forefront of service equipment, and how it’ll pay off:

These assets are counted on to save lives–so they better work.

Medical devices are expensive and often unique. A manufacturer like Elekta might only have 1,500 installations of a machine — there isn’t another machine for hundreds of miles — and even just a few minutes of outage could cost a hospital greatly. So manufacturers must guarantee these expensive machines continue to stay up and running.

More importantly, as Internet of Things technology gains adoption in the medical device space, it is totally changing the dynamic between manufacturer and medical facility. Through IoT-laced equipment and remote machine monitoring, a manufacturer can now guarantee uptime on medical machines. That means it’s no longer simply selling a product; it’s about guaranteeing an outcome. Be it hours of usage, x-ray output or another desired outcome, hospitals and doctors no longer need to worry about outages or calling in for service and can instead focus solely on patient well-being.

Regulations and rules force the industry to take data seriously.

The medical industry is highly regulated. Insurance firms, government directives and legalities keep the industry on guard when it comes to data collection and reporting. That kind of exposure has carved out a major opportunity for medical manufacturers in creating their equipment — and a major upsell to the industry.

By outfitting medical equipment with sensors and data collection capabilities, manufacturers can provide valuable information on how well they’re serving patients in the area. The metric-oriented medical industry is the perfect template to innovate around, with service technology as the catalyst for finding new ways of tracking activity and outcomes. As this service tech continues to advance, it will be smart for these medical manufacturers to stay abreast and on the cutting edge of building it into their machines to better take care of patients.

Make it a win-win for both sides.

There are major tangible benefits for medical-device manufacturers themselves when modernizing service. Manufacturers want to help their customers serve patients as best as possible over the course of every machine’s lifetime—and that can be done through increasing uptime, guaranteeing reliability and servicing machines quicker and more efficiently.

An IoT sensor on a hospital machine can report outages immediately after (if not before) they happen, allowing manufacturers to service machines at exactly the right time, which helps customers give essential treatments to patients and in turn makes manufacturers indispensably involved in saving lives.

It is a natural win-win situation and a shared investment in a positive outcome that can be strengthened through greater service technology.

January 06, 2017

Research Reports Initiation on Medical Equipment Stocks -- Stryker, Neovasc, Amedica, and ResMed

NEW YORK, January 5, 2017 /PRNewswire/ --

On Wednesday, January 04, 2017, US markets in general experienced broad based gains with all sectors ending the trading session in green. US indices followed suit as the NASDAQ Composite ended the day up 0.88%; the Dow Jones Industrial Average edged 0.30% higher; and the S&P 500 closed up 0.57%. Considering the current positive sentiment, Stock-Callers.com assesses the following Medical Equipment stocks: Stryker Corporation (NYSE: SYK), Neovasc Inc. (NASDAQ: NVCN), Amedica Corporation (NASDAQ: AMDA), and ResMed Inc. (NYSE: RMD). You can access of our complimentary research reports on these stocks now at:

http://stock-callers.com/registration

 

Stryker  

Kalamazoo, Michigan headquartered Stryker Corp.'s stock edged 0.56% higher, to close the day at $120.10. The stock recorded a trading volume of 1.50 million shares, which was above its three months average volume of 1.46 million shares. Stryker's shares have gained 7.53% in the last one month, 3.67% in the previous three months and 33.96% in the past one year. The Company's shares are trading 4.68% and 5.94% above its 50-day and 200-day moving averages, respectively. Shares of the Company, which together with its subsidiaries, operates as a medical technology company, are trading at a PE ratio of 27.38. Additionally, the stock has a Relative Strength Index (RSI) of 60.90. Visit us today and download your complete report on SYK for free at:

http://stock-callers.com/registration/?symbol=SYK


Neovasc  

On Wednesday, shares in Richmond, Canada headquartered Neovasc Inc. ended the session 8.05% higher at $1.88 with a total volume of 2.38 million shares traded. Neovasc's shares have rallied 118.60% in the last one month and 270.08% in the previous three months. The stock is trading 70.12% above its 50-day moving average and 44.59% above its 200-day moving average. Moreover, shares of the Company, develops, manufactures, and markets cardiovascular products worldwide, have an RSI of 59.60. The complimentary research report on NVCN can be accessed at:

http://stock-callers.com/registration/?symbol=NVCN

 

Amedica  

On Wednesday, shares in Salt Lake City, Utah headquartered Amedica Corp. recorded a trading volume of 184,103 shares. The stock ended the day 0.14% higher at $0.65. Amedica's stock has advanced 1.25% in the last one month. The Company is trading below its 50-day and 200-day moving averages by 8.26% and 38.32%, respectively. Furthermore, shares of Amedica, which develops, manufactures, and sells a range of medical devices based on its silicon nitride ceramic technology platform in the US, Europe, and South America, have an RSI of 49.89. Register for free on Stock-Callers.com and download the PDF research report on AMDA at:

http://stock-callers.com/registration/?symbol=AMDA


ResMed  

San Diego, California headquartered ResMed Inc.'s stock finished Wednesday's session 0.65% higher at $62.35 with a total volume of 759,493 shares traded. Over the last one month and the previous one year, ResMed's shares have gained 4.75% and 21.40%, respectively. The Company's shares are trading above its 50-day and 200-day moving averages by 3.35% and 1.33%, respectively. Shares of ResMed, which designs, develops, manufactures, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders, are trading at a PE ratio of 25.36. The stock has an RSI of 60.83. Get free access to your research report on RMD at:

http://stock-callers.com/registration/?symbol=RMD

 

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

 

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

 

CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number:  +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

 

SOURCE Chelmsford Park SA

December 12, 2016

Air Liquide creates EXPLOR! - a centre for evaluation of medical equipment

Air Liquide continues to develop new services in home healthcare, as with the creation of the EXPLOR! centre, a laboratory that evaluates the medical devices and new technologies used by patients suffering from chronic diseases.

Please reload